Stifel raised the firm’s price target on Colgate-Palmolive (CL) to $105 from $95 and keeps a Buy rating on the shares. The modest premium the firm applies compared to Procter & Gamble (PG) shares reflects expectations for superior organic sales and volume growth and gross margin expansion over the next 2-3 quarters and reflects accelerating volume trends and solid contribution from pricing, particularly high inflation markets, like Argentina, and in pet nutrition, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target raised to $91 from $85 at Barclays
- Colgate-Palmolive price target raised to $106 from $100 at Evercore ISI
- Colgate-Palmolive price target raised to $104 from $98 at Deutsche Bank
- Colgate-Palmolive price target raised to $110 from $100 at BofA
- Colgate-Palmolive price target raised to $112 from $103 at Citi
Questions or Comments about the article? Write to editor@tipranks.com